Missed Semaglutide or Tirzepatide Dose: What Now?

Identify the exact medication and formulation, your prescribed dose, the scheduled date you missed and the date and time of the last dose you actually took. A calendar entry saying “dose due” is not the same as confirmation that an injection was given. Check your log or ask a caregiver before assuming a dose was missed.

The rules below describe the FDA-approved brand injections, not a universal protocol for every semaglutide or tirzepatide prescription. If your label gives different instructions or you are uncertain about the elapsed time, contact your Join Luma clinician or dispensing pharmacist. Keep the label available so the team can confirm the product and concentration. Our weekly injection overview distinguishes this format from daily treatment.

For Wegovy injections, if the next scheduled dose is less than 2 days away, the label says not to administer the missed dose and to take the next dose on the regularly scheduled day. This is a countdown to your next planned injection, not a four-day window counted from the original missed dose.

If you are exactly at a timing boundary, have already changed your weekly day, or are unsure how to count the interval, ask your clinician or pharmacist instead of rounding in whichever direction seems convenient. The Wegovy prescribing information and Medication Guide is the source for this reference. Other semaglutide brand products can have different directions, so do not assume a rule for one brand applies to another.

The Zepbound prescribing information and Instructions for Use directs patients to take a missed dose as soon as possible within 4 days, or 96 hours, after the missed dose. If more than 4 days have passed, skip the missed dose and take the next one on the regularly scheduled day. The separate minimum spacing of 72 hours still matters.

Do not substitute semaglutide timing rules for tirzepatide timing rules. If a late dose would put your next injection too close, get individualized instructions rather than trying to catch up. Recording the actual administration time helps the care team plan the next safe interval.

Brand labels allow changing the weekly day when their minimum interval is met: Wegovy’s cited patient instructions use 2 or more days between doses, while Zepbound requires at least 3 days. These are scheduling rules for the labeled products, not an invitation to dose more frequently to speed weight loss.

For compounded treatment, ask your Join Luma clinician before moving a dose early. Provide the time of the last injection and the proposed new time, especially when crossing time zones. A day name alone can hide a short interval: “Monday” in one location and “Wednesday” in another does not necessarily tell you the exact hours.

Do not inject extra because appetite returns, because a holiday meal is coming or because a vial contains some liquid after the planned doses. Residual volume is not a prescription. For travel planning, use our travel and holiday schedule guide and confirm any proposed change before departure.

Contact your Join Luma clinician before restarting after more than two weeks off semaglutide. The Wegovy patient information also directs patients who miss 2 or more consecutive weeks to discuss restarting with their healthcare provider. After a break, returning directly to a previous higher dose can bring gastrointestinal problems.

Do not create your own restart ladder. Your clinician needs to know how many doses were missed, your last dose, how well you previously tolerated treatment and whether you stopped because of symptoms or another illness. For tirzepatide, ask for an individualized restart plan after multiple missed injections; the single missed-dose window does not answer every extended-interruption scenario.

Check whether the vial is still within its beyond-use date and post-puncture instructions. A schedule interruption does not extend a pharmacy’s use-by limit. The compounded medication storage guide explains why product-specific directions matter.

A late injection does not automatically mean you should increase the next dose, repeat a week or finish the remaining vial faster. Titration decisions depend on tolerability and the actual doses received. Let your Join Luma clinician decide whether the planned increase still makes sense.

This is especially important after vomiting, poor fluid intake or a measurement error. Seek urgent care for severe abdominal pain, persistent vomiting or dehydration; call 911 for breathing trouble or facial or throat swelling. A dosing-calendar question should never delay urgent assessment of a potentially serious reaction.

For routine questions, send the medication name, label photo, last actual injection date and time, missed scheduled date, current symptoms and your proposed next dose time. That is more useful than “Can I take it today?” without context. Support is available through the patient portal or support@joinluma.com, but routine support is not emergency care.

Your prescription label and Join Luma clinician’s directions take priority over general information about brand-name products. Compounded semaglutide and compounded tirzepatide are not FDA-approved. FDA-approved brand labels provide useful reference information, but their devices, concentrations, storage allowances and study results do not automatically apply to a compounded prescription.

The Understanding the Risks of Compounded Drugs explains this distinction. Keep the pharmacy label available when asking a question: it identifies the medication, concentration, directions and beyond-use date. A photograph of that label and the supplied syringe can help the care team resolve a measurement question without guessing. Never use someone else’s dose or syringe marking as your own instructions.